Researchers at the University of Virginia are tracking the new COVID-19 variant Omicron, but there are some concerns about how fast the search is going. Once doctor says data collection is running behind.
Scott Kennedy had to quarantine for two weeks in South Africa and then he was cleared to fly back home. That was last Friday, when the world reacted to Omicron, and his flight out of Africa was canceled.
A World Health Organization panel named the variant “omicron” and classified it as a highly transmissible virus of concern, the same category that includes the delta variant, the world’s most prevalent.
Booster vaccines can be given to anyone 18 years and older at least six months from the date of their second mRNA (Pfizer-BioNTech or Moderna) vaccination or two months from the date of their Johnson and Johnson vaccine.
Through snowstorms and Hurricane Isabel, the Veterinary Referral and Critical Care hospital in Goochland has kept its doors unlocked but on Sunday for the first time in almost 25 years, the animal hospital was closed.
otal hospitalizations in Virginia plummeted at the start of the pandemic, and they still haven’t fully recovered. Friday morning, the Virginia Hospital and Healthcare Association briefed reporters on data from more than 90 hospitals around the state.
Hampered by rising COVID-19 cases and persistent supply shortages, the U.S. economy slowed to a 2% annual rate in the July-September period, the weakest quarterly growth since the recovery from the pandemic recession began last year.
Over the next two weeks, the Virginia Department of Health (VDH) says private providers, like pediatricians, will get about 252,000 doses of Pfizer’s COVID-19 vaccine for 5 to 11 year olds. Another 125,000 will be shipped directly to pharmacies.
The FDA’s Doran Fink previewed “some announcements later today,” which were expected to include allowing the mixing and matching of COVID-19 booster doses among the three U.S. manufacturers — Pfizer, Moderna and J&J. Fink appeared at a meeting of vaccine experts convened by the Centers for Disease Control and Prevention, who are expected to take up the FDA decisions and make their own recommendations on Thursday.